1. Genotype-based selection of treatment of patients with advanced colorectal cancer (SETICC): a pharmacogenetic-based randomized phase II trial. (14th November 2017) Authors: Abad, A; Martínez-Balibrea, E; Viéitez, J M; Alonso-Orduña, V; García Alfonso, P; Manzano, J L; Massutí, B; Benavides, M; Carrato, A; Zanui, M; Gallego, J; Grávalos, C; Conde, V; Provencio, M; Valladares-Ayerbes, M; Salazar, R; Sastre, J; Montagut, C; Rivera, F; Aranda, E Journal: Annals of oncology Issue: Volume 29:Number 2(2018) Page Start: 439 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Phase II study of high-sensitivity genotyping of KRAS, NRAS, BRAF and PIK3CA to ultra-select metastatic colorectal cancer patients for panitumumab plus FOLFIRI: the ULTRA trial. (6th March 2019) Authors: Santos, C; Azuara, D; Viéitez, J M; Páez, D; Falcó, E; Élez, E; López-López, C; Valladares, M; Robles-Díaz, L; García-Alfonso, P; Bugés, C; Durán, G; Salud, A; Navarro, V; Capellá, G; Aranda, E; Salazar, R Journal: Annals of oncology Issue: Volume 30:Number 5(2019) Page Start: 796 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Ultra-selection of metastatic colorectal cancer patients using next-generation sequencing to improve clinical efficacy of anti-EGFR therapy. (23rd January 2019) Authors: Vidal, J; Bellosillo, B; Santos Vivas, C; García-Alfonso, P; Carrato, A; Cano, M T; García-Carbonero, R; Élez, E; Losa, F; Massutí, B; Valladares-Ayerbes, M; Viéitez, J M; Manzano, J L; Azuara, D; Gallego, J; Pairet, S; Capellá, G; Salazar, R; Tabernero, J; Aranda, E Journal: Annals of oncology Issue: Volume 30:Number 3(2019) Page Start: 439 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗